Single Dose Suspension 10ml
Vermox SD Single Dose Suspension 10ml is scientifically formulated with special ingredients proven to kill intestinal worms, such as pinworm, hookworm, large roundworm and whipworm.
Medical aid prices may differ from the cash price displayed.
Any questions? Visit our OTC FAQ page for more information.
Infections 1and2 Stomach And Colon Health Vermox Suspension 10 ml
Proprietary name (and dosage form):Vermox® SD suspension.Composition:Each bottle (10 ml suspension) contains 500 mg of the active substance, mebendazole polymorph C. Preservatives: methylparaben 0,18% m/v and propylparaben 0,02% m/v ethyl alcohol content: 0,48 % v/v.Pharmacological classification:A.12 anthelmintics, bilharzia medicines, filaricides, etc.Pharmacological action:Mebendazole is a broad-spectrum anthelmintic. Mebendazole acts locally in the lumen of the gut by interfering with cellular tubulin formation in the intestines of worms. Mebendazole binds specifically to tubulin and causes ultrastructural degenerative changes in the intestine. As a result, the glucose uptake and the digestive functions of the worm are disrupted to such an extent that an autolytic process occurs.Indications:Vermox® is indicated for the treatment of single and mixed helminth gastrointestinal infestations caused by:Nematodes such as:Trichuris trichiura - (whipworm).Ancylostoma duodenale - (hookworm).Necator americanus - (hookworm).Ascaris lumbricoides - (large roundworm).Enterobius vermicularis - (pinworm).Clinical trial data:The safety of Vermox® was evaluated in 6276 subjects who participated in 39 clinical trials for the treatment of single or mixed parasitic infestations of the gastrointestinal tract. In these 39 clinical trials, no adverse drug reactions (ADRs) occurred in >1 % of Vermox®-treated subjects. ADRs occurring in < 1% of Vermox® - treated subjects are shown in table 1.Table 1. Adverse drug reactions reported by < 1 % of Vermox® - treated subjects in 39 clinical trials.System/organ class:Adverse reaction.Gastrointestinal disorders.Abdominal discomfort.Diarrhoea.Flatulence.Skin and subcutaneous tissue disorders.Rash.Postmarketing experience:Adverse drug reactions first identified during post-marketing experience with Vermox® (mebendazole) are included below:System/organ class.Adverse reaction.Blood and lymphatic system disorders.Neutropenia.Immune system disorders.Hypersensitivity including anaphylactic reaction and anaphylactoid reaction.Nervous system disorders.Convulsions.Gastrointestinal disorders.Abdominal pain.Hepatobiliary disorders.Hepatitis, abnormal liver function tests.Skin and subcutaneous tissue disorders.Toxic epidermal necrolysis, Stevens Johnson syndrome, exanthema, angioedema, urticaria, alopecia.Identification:White to off-white suspension with a chocolate flavour.Presentation:15 ml amber glass bottles containing 10 ml Vermox® SD suspension.Customer contact centre: 0860 410032 (South Africa only).
Quantity in pack: